Researchers conducted a study to compare the effects of intravenous vs oral antibiotics therapy in patients with a pulmonary infection caused by Pseudomonas aeruginosa secondary to cystic fibrosis.
Is breathing reserve an adequate measure of ventilatory limitation in patients with cystic fibrosis?
Can proteomics identify biomarkers of infection, disease severity, and treatment
response in patients with non-tuberculous mycobacterial lung infection?
Swiss researchers studied pediatric patients with cystic fibrosis to determine their functional response to nebulized inhalation with salbutamol.
Investigators assessed which factors contribute to risk for GI-related hospitalizations in infants with cystic fibrosis.
Can an intervention approach emphasizing habit formation improve treatment adherence and outcomes for patients with cystic fibrosis?
A clinical trial showed ELX-TEZ-IVA had benefits over other CFTR modulators for patients with Phe508del-gating or Phe508del-residual function genotypes.
Investigators compared functional respiratory imaging with validated imaging parameters and classical respiratory outcomes in patients with cystic fibrosis.
Researchers sought to delineate the role of cystic fibrosis transmembrane conductance regulator (CFTR) in pulmonary arterial hypertension pathogenesis through observational and interventional experiments in human tissues and animal models.
Researchers compared clinical outcomes of single vs double antipseudomonal antibiotics used to treat pulmonary exacerbations in patients with cystic fibrosis.
